home / stock / pasg / pasg short
Short Information | Passage Bio Inc. (NASDAQ:PASG)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 198,064 |
Total Actual Volume | 1,901,864 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 9,903 |
Average Short Percentage | 11.60% |
Is there a PASG Short Squeeze or Breakout about to happen?
See the PASG Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-05-2024 | $0.91 | $0.916 | $0.9379 | $0.9 | 20,844 | 1,896 | 9.1% |
07-03-2024 | $1.01 | $0.8917 | $1.02 | $0.8511 | 68,100 | 2,700 | 3.96% |
07-02-2024 | $0.99 | $0.9996 | $1.03 | $0.99 | 160,810 | 11,940 | 7.42% |
07-01-2024 | $0.81 | $0.885 | $0.93 | $0.79 | 317,551 | 43,072 | 13.56% |
06-28-2024 | $0.95 | $0.7942 | $0.95 | $0.7942 | 256,294 | 6,388 | 2.49% |
06-27-2024 | $0.92 | $0.9239 | $0.924 | $0.91 | 15,767 | 4,165 | 26.42% |
06-26-2024 | $0.93 | $0.912 | $0.9599 | $0.89 | 37,038 | 2,039 | 5.51% |
06-25-2024 | $0.93 | $0.912 | $0.9766 | $0.91 | 28,267 | 2,972 | 10.51% |
06-24-2024 | $0.91 | $0.91 | $0.96 | $0.8882 | 46,561 | 2,229 | 4.79% |
06-21-2024 | $0.93 | $0.91 | $0.96995 | $0.8801 | 186,175 | 8,889 | 4.77% |
06-20-2024 | $0.9512 | $0.93 | $0.987 | $0.880101 | 71,724 | 10,766 | 15.01% |
06-18-2024 | $1 | $0.955 | $1.02 | $0.91 | 115,105 | 10,496 | 9.12% |
06-17-2024 | $1.05 | $1.01 | $1.09 | $1 | 32,082 | 3,131 | 9.76% |
06-14-2024 | $1.07 | $1.05 | $1.09 | $1.01 | 38,000 | 7,717 | 20.31% |
06-13-2024 | $1.04 | $1.07 | $1.0856 | $1.01 | 45,046 | 8,806 | 19.55% |
06-12-2024 | $1.06 | $1.04 | $1.33 | $1 | 236,762 | 41,062 | 17.34% |
06-11-2024 | $1.08 | $1.09 | $1.11 | $1.02 | 51,678 | 6,232 | 12.06% |
06-10-2024 | $1.19 | $1.09 | $1.19 | $1.08 | 61,803 | 8,523 | 13.79% |
06-07-2024 | $1.22 | $1.185 | $1.23 | $1.1501 | 37,061 | 4,808 | 12.97% |
06-06-2024 | $1.29 | $1.24 | $1.3 | $1.2 | 75,196 | 10,233 | 13.61% |
News, Short Squeeze, Breakout and More Instantly...
PHILADELPHIA, June 05, 2024 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ: PASG), a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases, today announced that William Chou, M.D., president and chief executive officer, will present at ...
PHILADELPHIA, May 21, 2024 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (Nasdaq: PASG), a clinical stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases, today announced Carrie Gordon, a sophomore at Drexel University, as the third recipient of i...